SeekingAlpha · Jul 17, 2026
Orion Oyj (ORINF) Q2 2026 Earnings Call Transcript
Orion Oyj (ORINF) Q2 2026 Earnings Call July 17, 2026 7:00 AM EDTCompany ParticipantsTuukka Hirvonen - Investor Relations & Financial Communications...
OTC · ORINY
Healthcare · Drug Manufacturers - General
$47.13
Up+$1.37 (+2.98%)
Updated Sep 4, 2026, 8:09 AM
SID Score
5.2/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
ORINY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning ORINY.
ORINY research
Company profile and research snapshot.
ORION CORP NEW UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Jul 17, 2026
Orion Oyj (ORINF) Q2 2026 Earnings Call July 17, 2026 7:00 AM EDTCompany ParticipantsTuukka Hirvonen - Investor Relations & Financial Communications...
SeekingAlpha · Jul 17, 2026
2026-07-17. The following slide deck was published by Orion Oyj in conjunction with their 2026 Q2 earnings call.
Yahoo · Jul 6, 2026
DHARWAD, India, July 06, 2026--Shilpa Medicare and Orion Corporation expand partnership to develop and supply intravenous nivolumab biosimilar to widen patient access across Europe.
SeekingAlpha · Apr 23, 2026
Orion Oyj (ORINF) Q1 2026 Earnings Call April 23, 2026 7:00 AM EDTCompany ParticipantsTuukka Hirvonen - Investor Relations & Financial Communications...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ORINY.